C07D 455/02
Containing not further condensed quinolizine ring systems
Official title: containing not further condensed quinolizine ring systems
C07D455/02 (Containing not further condensed quinolizine ring systems) appears on 173 US grants and 130 published applications in this corpus.
Search patents in C07D- Granted patents
- 173
- Published applications
- 130
- Assignees
- 101
- Inventors
- 579
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 8 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 4 |
| 2003 | 6 | 8 |
| 2004 | 3 | 9 |
| 2005 | 6 | 5 |
| 2006 | 5 | 6 |
| 2007 | 5 | 3 |
| 2008 | 0 | 2 |
| 2009 | 2 | 4 |
| 2010 | 3 | 7 |
| 2011 | 2 | 10 |
| 2012 | 11 | 2 |
| 2013 | 2 | 4 |
| 2014 | 0 | 8 |
| 2015 | 5 | 5 |
| 2016 | 4 | 4 |
| 2017 | 4 | 6 |
| 2018 | 4 | 4 |
| 2019 | 5 | 2 |
| 2020 | 2 | 4 |
| 2021 | 4 | 5 |
| 2022 | 3 | 5 |
| 2023 | 2 | 9 |
| 2024 | 4 | 5 |
| 2025 | 5 | 2 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof28 Apr 2026US 12,612,403 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Heterocyclic compound21 Oct 2025US 12,448,377 B2Takeda Pharmaceutical Company Limited
- Nanomaterials7 Oct 2025US 12,435,035 B2Guide Therapeutics, LLC
- Substituted benzenecarboxamides as IL-17A modulators23 Sep 2025US 12,421,212 B2Dice Alpha, Inc.
- Modulators of STING (stimulator of interferon genes)13 May 2025US 12,297,190 B2Pfizer Inc.
- Heteroaryl enhancers of the particulate guanylyl cyclase receptor a27 Aug 2026US 2026/0250275 A1University of Florida Research Foundation, Inc.
- Inhibitors of NLRP313 Aug 2026US 2026/0234123 A1
- Compounds for treating opioid misuse13 Aug 2026US 2026/0234147 A1University of Florida Research Foundation, Inc.
- Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof9 Jul 2026US 2026/0193260 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Glucosylceramide synthase inhibitors18 Jun 2026US 2026/0167645 A1Genzyme Corporation
Most cited
By later US patents
- Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds48US 5,703,244 AAbbott Laboratories · 1997
- Centrally acting substituted phenylazacycloalkanes35US 5,462,947 AThe Upjohn Company · 1995
- Cyclic compounds34US 7,897,607 B2Takeda Pharmaceutical Company Limited · 2011
- Quinolizinone type compounds32US 5,599,816 AAbbott Laboratories · 1997
- Quinolizinone type compounds30US 5,580,872 AAbbott Laboratories · 1996